FDA approves pembrolizumab to treat cHLMarch 15, 2017Lymphoma & Plasma Cell DisordersPharmacyHodgkin LymphomaAggressive Lymphomas
Family history impacts risk of second cancer after HLMarch 14, 2017Lymphoma & Plasma Cell DisordersHodgkin LymphomaAggressive Lymphomas
Immunotherapy receives fast track designationFebruary 22, 2017Lymphoma & Plasma Cell DisordersTransplantationHodgkin LymphomaNon-Hodgkin LymphomaAggressive Lymphomas
Styrene exposure linked to myeloid leukemia, HLFebruary 16, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersAMLHodgkin LymphomaCMLAggressive Lymphomas
How EBV causes lymphoma, other cancersFebruary 14, 2017Lymphoma & Plasma Cell DisordersHodgkin LymphomaAggressive Lymphomas
Study quantifies 5-year survival rates for blood cancersJanuary 25, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaAMLALLHodgkin LymphomaCML
Combined checkpoint blockade promising in HLDecember 22, 2016Lymphoma & Plasma Cell DisordersHodgkin Lymphoma
Why some patients relapse: The case for consolidation therapy in Hodgkin lymphomaDecember 21, 2016Lymphoma & Plasma Cell DisordersHodgkin Lymphoma
Group estimates global cancer cases, deaths in 2015December 8, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaRelated IssuesAMLALLHodgkin Lymphoma
FDA grants priority review to sBLA for pembrolizumabDecember 2, 2016Lymphoma & Plasma Cell DisordersPharmacyHodgkin Lymphoma
EC approves nivolumab for relapsed/refractory cHLNovember 23, 2016Lymphoma & Plasma Cell DisordersPharmacyHodgkin Lymphoma
Drug elicits responses in heavily pretreated cHLNovember 8, 2016Lymphoma & Plasma Cell DisordersHodgkin Lymphoma
Burden of cancer varies by cancer type, raceOctober 20, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaRelated IssuesHodgkin LymphomaNon-Hodgkin Lymphoma
Cancer report details progress, predicts problemsSeptember 21, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaHematology NursingPediatricsRelated IssuesHodgkin Lymphoma
Native Israelis have higher risk of Hodgkin lymphomaAugust 26, 2016Lymphoma & Plasma Cell DisordersHodgkin Lymphoma